Blog - Page 1402 of 5718

WednesdayMay 05, 2021 12:29 pm

QualityStocksNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Provides Update on Beyond Tobacco(TM) Patent Filing

TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) has announced that its Beyond Tobacco(TM) patent filing has advanced to the nonprovisional status. The company submitted the patent filing for its exclusive process that is used to produce Beyond Tobacco’s taste and smell that is similar to tobacco. The filing was submitted to the United States Patent and Trademark Office in September 2020. The patent will protect the refinement technique that characterizes both TAAT(TM) and its Beyond Tobacco base material. The company believes that the patent will prove valuable as the company focuses on establishing a market position and…

WednesdayMay 05, 2021 12:14 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures Centralized IRB Approval for Acclaim-1 Clinical Trial

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced its receipt of centralized Institutional Review Board (“IRB”) approval of the clinical trial protocol for its upcoming Acclaim-1 clinical trial in non-small cell lung cancer (“NSCLC”). Acclaim-1 is an open-label, multi-center Phase 1/2 clinical trial that combines the company’s lead drug candidate, REQORSA(TM) immunogene therapy, with AstraZeneca’s Tagrisso(R) (osimertinib) in patients with late-stage NSCLC with mutated epidermal growth factor receptors (“EGFRs”), whose disease progressed after treatment with Tagrisso. “The purpose of IRB review is to assure that appropriate steps…

WednesdayMay 05, 2021 12:08 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Signs Drug-Development Agreement, One Step Closer to Effective Psychiatric Disorder Treatment

Agreement calls for Cybin, Catalent to work together to develop novel therapy for treatment-resistant psychiatric disorders Cybin looking to identify fast-acting, shorter-duration formulations of CYB003 Delivering CYB003 through Catalent ODT could provide significant benefits Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has inked a drug-development agreement with Catalent Inc. (NYSE: CTLT), a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products (https://ibn.fm/nQdpg). The agreement, which is scheduled to start this month, calls for the two companies to work together to potentially…

WednesdayMay 05, 2021 11:31 am

Current Deficiencies in The Rational Development of CBD-based Wellness Products

Even major players in the CBD market do not offer detailed and verifiable study results to effectively differentiate their products on the basis of meaningful clinical findings, essentially exploiting the “natural” label without any R&D efforts This industry deficiency represents immense opportunities for R&D-driven companies such as Green Hygienics Green Hygienics intends to use its intellectual and capital resources to establish and apply state-of-the-art research and development to a new generation of cannabinoid-based products having specifically assessed health-wellness efficacies CBD Reality Check Interest in the therapeutic use of hemp-derived nonintoxicating cannabinoids, such as cannabidiol (“CBD”) and cannabigerol (“CBG”), has reached…

WednesdayMay 05, 2021 10:25 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) Rail Vision Enters Agreement to Supply Proof-of-Concept Prototype

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its affiliate, Rail Vision Ltd., has entered an agreement with Hitachi Rail STS Australia Pty Ltd. to supply equipment, services and personnel to the Australian rail company Rio Tinto Railway Network. Under the agreement, Hitachi Rail STS, the project integrator, will provide Rio Tinto with a prototype of Rail Vision’s Collision Avoidance System to undergo demonstration and feasibility testing for a proof-of-concept project. Project revenue is expected to total $265,000, with an option for Rail Vision to furnish additional services for $133,000. To view…

WednesdayMay 05, 2021 10:12 am

QualityStocksNewsBreaks –Splash Beverage Group Inc. (SBEV) Announces Distribution Agreement for SALT Naturally Flavored Tequila

Splash Beverage (OTCQB: SBEV), a holding company with a leading portfolio of beverage brands, has finalized an arrangement with Pepin Distributing for its SALT Naturally Flavored 100% Agave Tequila line. SALT Naturally Flavored Tequila will join the more than 168 premier brands distributed by Pepin Distributing, which is based in Tampa, Florida. Pepin already handles Splash Beverage’s Copa di Vino. SALT Naturally Flavored Tequila is 100% agave, 80 proof naturally flavored tequila that is grown, distilled and battled in Mexico. Every bottle of smooth SALT Tequila, which is available in a variety of natural flavors including Berry, Citrus and Salted Chocolate,…

WednesdayMay 05, 2021 9:45 am

QualityStocksNewsBreaks – Sanwire Corp.’s (SNWR) Intercept Music Signs Godsize Records

Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment industry, together with its 100% wholly owned subsidiary, Intercept Music Inc., today announced the signing of Godsize Records to its Label Incubator Program. According to the update, Godsize Records is a blooming new upstart label that focuses on new rock talent based in the United States. "Godsize Records is a great addition to our Label Incubator Program, and we see many synergies between the companies," said Tod Turner, president of Intercept Music. "We are excited to help them develop their artists with our industry first products…

WednesdayMay 05, 2021 9:43 am

QualityStocksNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Share FusionOne Waste to Power Tech Update

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, earlier invested in FusionOne Energy Corp. and recently shared an update on that investment. FusionOne is a private, end-to-end technology and operations company specializing in renewable electricity, white hydrogen production and thermal processing technologies. The company has created technology designed for the conversion of plastic waste to hydrogen and clean electricity. According to the update, FusionOne’s fabrication facility has begun production of the HydroPlas continuous cycle reactor, a key component of FusionOne’s efficient hydrogen-producing system. The reactor, along with other supporting proprietary technologies are slated for a Q3…

WednesdayMay 05, 2021 9:15 am

H.C. Wainwright Publishes Analyst Research Report on Uranium Energy Corp. (NYSE American: UEC), Reiterates Buy Rating

Brokerage firm H.C. Wainwright & Co. recently released report featuring UEC, reiterates Buy rating Recent drilling activities at UEC’s Burke Hollow in situ recovery (“ISR”) project show strong results, potential for further resource growth UEC well-financed to aggressively pursue key developmental targets, the Company has over $110 million in cash, equity and inventory holdings UEC is production ready with four fully licensed uranium projects and a state-of-the-art Central Processing plant with a combined production profile of 4 million pounds of uranium per year Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, was recently featured…

Site Search

Company Search